8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Cardinal Health Extends CVS Health Distribution Agreement Through 2032
Filed with the SEC on · Summarized by InvestorsBot
Cardinal Health signed a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032, with the current scope of services continuing. The company reaffirmed fiscal 2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth, and long-term non-GAAP EPS growth guidance of 12% to 14%; further updates may come with its November 5, 2026 earnings call.